Actinogen Medical progresses in XanaMIA Phase 2b/3 trial for Alzheimer’s disease
Actinogen Medical Limited (ASX: ACW) has announced a major milestone in its ongoing XanaMIA Phase 2b/3 clinical trial, aimed at treating biomarker-positive mild to moderate ... Read More
The Pulse of Cloud: Wipro’s July 2024 report exposes explosive growth in AI-driven cloud investments!
The Pulse of Cloud: Quarterly Report July 2024 from Wipro reveals a significant surge in cloud investments, driven by advancements in artificial intelligence (AI) and ... Read More
Russia seeks US intelligence on Ukraine’s alleged role in Moscow concert hall attack
In a tense international accusation, Russia has charged the United States with withholding intelligence about Ukraine's purported 'involvement' in a devastating terror attack at a ... Read More
Lupin Limited launches Generic Suprep Bowel Prep Kit in the US
Indian pharma company Lupin Limited has launched Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution, 17.5 g/3.13 g/1.6 g per 6 ounces, after getting ... Read More
Zydus Lifesciences launches Revlimid generic – Lenalidomide Capsules in US
Indian pharma company Zydus Lifesciences Limited, previously known as Cadila Healthcare Limited has launched Lenalidomide Capsules, a generic of Revlimid, in the US market. The ... Read More